Dr. Jianle Wang represents pharmaceutical and biotech companies on the procurement and protection of intellectual property. Jianle's practice encompasses global patent portfolio development and management, due diligence investigation, patentability and validity assessments, freedom-to-operate analysis, and patent strategy counseling.
Jianle has experience with a wide range of technologies, including immunotherapies (e.g., antibodies, antibody-drug conjugates, cell-based therapies, CAR-T cell technology), biomarkers and diagnostics, small-molecule pharmaceuticals, cancer treatment, stem cells, and therapeutic polypeptides.
Jianle has worked on representative matters for Merck, AbbVie, and NGM Biopharmaceuticals.
Prior to joining Jones Day, Jianle worked as a scientist for more than 10 years and performed her postdoctoral research at the University of Pennsylvania.
Jianle is actively involved in the Firm's pro bono practice that includes representing individuals seeking asylum in the United States.
Experience
- The George Washington University (J.D. with honors 2022; Thurgood Marshall Scholar); University of Chinese Academy of Sciences (Ph.D. in Developmental Biology 2010); Shandong Normal University (B.S. in Biotechnology 2004)
- California and registered to practice before the United States Patent and Trademark Office
- Chinese